Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Controlled drugs

Scientists use crowdfunding to boost LSD research

Scientists have turned to crowdfunding to support an imaging study showing the effects of LSD on the brain, the first to be conducted in the UK.

The team has begun a psychedelic research programme with £100,000 of funding from The Beckley Foundation. However, the group needs a further £25,000, which they are attempting to raise through the crowdfunding website Walacea. The crowdfunding campaign will run for 45 days from 5 March 2015.

“Political stigma has silenced research,” says David Nutt, the principal investigator and a professor of neuropsychopharmacology at Imperial College London.

The researchers used functional MRI and magnetoencephalography imaging to record the effects of a 75μg IV dose of LSD given to 20 subjects. Additional funding is needed to fully analyse the results.

 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20068091

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.